BH-F Stock Overview

Owns and operates healthcare-related entities in Thailand and internationally. More details

BH-F fundamental analysis
Snowflake Score
Valuation	3/6
Future Growth	2/6
Past Performance	5/6
Financial Health	6/6
Dividends	5/6

Rewards

Trading at 18.3% below our estimate of its fair value

Earnings are forecast to grow 3.21% per year

Earnings grew by 11.1% over the past year

Pays a reliable dividend of 2.66%

Risk Analysis

Shares are highly illiquid

My Notes

Capture your thoughts, links and company narrative

Bumrungrad Hospital Public Company Limited Competitors

Bangkok Dusit Medical Services

SET:BDMS

฿373.5b

Vibhavadi Medical Center

SET:VIBHA

฿25.8b

Praram 9 Hospital

SET:PR9

฿20.2b

Master Style

SET:MASTER

฿13.5b

Price History & Performance

Summary of share price highs, lows and changes for Bumrungrad Hospital
Historical stock prices
Current Share Price	฿189.50
52 Week High	฿275.00
52 Week Low	฿185.00
Beta	0.22
1 Month Change	-29.55%
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	1,289.09%

Recent updates

Shareholder Returns

	BH-F	TH Healthcare	TH Market
7D	-1.0%	-3.5%	-4.7%
1Y	n/a	-15.5%	-3.4%

Return vs Industry: Insufficient data to determine how BH-F performed against the TH Healthcare industry.

Return vs Market: Insufficient data to determine how BH-F performed against the TH Market.

Price Volatility

Is BH-F's price volatile compared to industry and market?
BH-F volatility
BH-F Average Weekly Movement	n/a
Healthcare Industry Average Movement	4.1%
Market Average Movement	4.3%
10% most volatile stocks in TH Market	8.9%
10% least volatile stocks in TH Market	2.1%

Stable Share Price: BH-F's share price has been volatile over the past 3 months compared to the TH market.

Volatility Over Time: Insufficient data to determine BH-F's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1975	n/a	Artirat Charukitpipat	www.bumrungrad.com

Bumrungrad Hospital Public Company Limited owns and operates healthcare-related entities in Thailand and internationally. It operates allergy, arrhythmia, behavioral health, breast, home service, heart valve, robotic surgery, rehabilitation, children's, colorectal surgery, complex coronary artery intervention, cornea transplant, dental, diagnostic, dialysis, digestive disease, ear, nose, throat, emergency, endocrinology, diabetes, expatriate liaison, eye, fertility, gastrointestinal motility, health screening, holistic wound care, horizon regional cancer, hyperbaric oxygen therapy, nephrology, neuroscience, orthopedics, perinatal, plastic surgery, pulmonary, refractive surgery, robotic scoliosis, skin, sports medicine and joint, surgery, travel medicine, urology, scientific wellness, skin and aesthetic, and women's centers. The company also operates breastfeeding, Yangon, COVID-19 recovery, comprehensive sleep, IVF, hearing and balance, medical, memory, new life healthy aging, Parkinson's disease and movement disorders, pride, surgery, vaccine clinics.

Bumrungrad Hospital Public Company Limited Fundamentals Summary

How do Bumrungrad Hospital's earnings and revenue compare to its market cap?
BH-F fundamental statistics
Market cap	฿153.82b
Earnings (TTM)	฿7.59b
Revenue (TTM)	฿25.89b

20.3x

P/E Ratio

5.9x

P/S Ratio

Is BH-F overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BH-F income statement (TTM)
Revenue	฿25.89b
Cost of Revenue	฿12.58b
Gross Profit	฿13.31b
Other Expenses	฿5.72b
Earnings	฿7.59b

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

Feb 27, 2025

Earnings per share (EPS)	9.55
Gross Margin	51.42%
Net Profit Margin	29.33%
Debt/Equity Ratio	0.09%

How did BH-F perform over the long term?

See historical performance and comparison

Dividends

2.7%

Current Dividend Yield

54%

Payout Ratio

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/22 07:09
End of Day Share Price	2024/12/19 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Bumrungrad Hospital Public Company Limited is covered by 50 analysts. 19 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Kawee Manitsupavong	Asia Plus Securities Company Limited
Weiyee In	BNP Paribas Securities (Asia)
Chutima Woramontri	BNP Paribas Securities (Asia)